Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding the Importance of the Microbiome and Metabolome in IBD Patients

NCT04998084 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.

NCT NCT04998084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04998084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding the Importance of the Microbiome and Metabolome in IBD Patients
Lead sponsor
Tel-Aviv Sourasky Medical Center
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2019
Completion date
June 27, 2025
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, pouchitis, ulcerative colitis